Asterias Biotherapeutics, Inc. Retained Earnings
Asterias Biotherapeutics, Inc. had Retained Earnings of -$132.26 million as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-11-09
- 2018-09-30: Retained Earnings (Accumulated Deficit) -$132.26M.
- 2018-06-30: Retained Earnings (Accumulated Deficit) -$127.81M.
- 2018-03-31: Retained Earnings (Accumulated Deficit) -$120.83M.
- 2017-12-31: Retained Earnings (Accumulated Deficit) -$112.10M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2018-09-30 | -$132.26M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$127.81M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$120.83M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$112.10M 10-Q · filed 2018-11-09 | |
| 2017-09-30 | -$105.55M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$98.74M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$90.02M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$83.73M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$74.38M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$63.73M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$58.58M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$48.24M 10-K · filed 2017-03-28 | |
| 2015-09-30 | -$43.33M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$39.83M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$36.21M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$33.24M 10-K · filed 2016-03-29 | -$33.24M 10-K · filed 2015-03-11 |
| 2014-09-30 | -$29.91M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$28.23M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$25.43M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$23.14M 10-K · filed 2015-03-11 | |
| 2013-09-30 | -$5.57M 10-Q · filed 2013-11-12 | |
| 2012-12-31 | -$758.89K 10-K · filed 2014-03-17 |